D.C. Mun. Regs. tit. 22, r. 22-B1205

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 22-B1205 - SCHEDULE V ENUMERATED

1205.1

The following controlled substances listed below are included in Schedule V of the Act unless removed therefrom pursuant to Section 201 of the Act:

(a) Narcotic drugs containing non-narcotic active medicinal ingredients: Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or salts thereof, that also contains one (1) or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal quantities other than those possessed by the narcotic drug alone:

(1) Not more than two hundred (200) milligrams of codeine per one hundred (100) milliliters or per one hundred (100) grams;

(2) Not more than one hundred (100) milligrams of dihydrocodeine per one hundred (100) milliliters or per one hundred (100) grams;

(3) Not more than one hundred (100) milligrams of ethylmorphine per one hundred (100) milliliters or per one hundred (100) grams;

(4) Not more than two and five-tenths (2.5) milligrams of diphenoxylate and not less than twenty -five (25) micrograms of atropine sulfate per dosage unit;

(5) Not more than one hundred (100) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams;

(6) Not more than one half-tenth (0.5) milligrams of Difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit;

(b) repealed.

(c) Pyrovalerone; and

(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

(1) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester];

(2) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy -propionamide]; and

(3) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].

D.C. Mun. Regs. tit. 22, r. 22-B1205

Final Rulemaking published at 39 DCR 1882, 1892 (March 20, 1992); Notice of Emergency and Proposed Rulemaking published at 47 DCR 7512 (September 15, 2000) [EXPIRED]; as amended by Final Rulemaking published at 48 DCR 914 (February 2, 2001); as amended by Notice of Emergency and Proposed Rulemaking published at 50 DCR 10421 (December 5, 2003) [EXPIRED]; as amended by Final Rulemaking published at 51 DCR 4080 (April 23, 2004); as amended by Final Rulemaking published at 61 DCR 10233 (October 3, 2014); Final Rulemaking published at 39 DCR 1882, 1892 (March 20, 1992); Notice of Emergency and Proposed Rulemaking published at 47 DCR 7512 (September 15, 2000) [EXPIRED]; as amended by Final Rulemaking published at 48 DCR 914 (February 2, 2001); as amended by Notice of Emergency and Proposed Rulemaking published at 50 DCR 10421 (December 5, 2003) [EXPIRED]; as amended by Final Rulemaking published at 51 DCR 4080 (April 23, 2004); as amended by Final Rulemaking published at 61 DCR 10233 (October 3, 2014); amended by Final Rulemaking published at 64 DCR 635 (1/26/2018, as corrected by Errata by Final Rulemaking published at 64 DCR 1633 (2/16/2018); amended by Final Rulemaking published at 66 DCR 002327 (2/22/2019); amended by Final Rulemaking published at 67 DCR 14204 (12/4/2020)